Vanda Pharmaceuticals
VNDA
VNDA
178 hedge funds and large institutions have $723M invested in Vanda Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 59 increasing their positions, 63 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 63
71% less call options, than puts
Call options by funds: $731K | Put options by funds: $2.51M
Holders
178
Holding in Top 10
1
Calls
$731K
Puts
$2.51M
Top Buyers
| 1 | +$7.36M | |
| 2 | +$6.46M | |
| 3 | +$5.73M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$4.59M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.65M |
Top Sellers
| 1 | -$8.43M | |
| 2 | -$4.7M | |
| 3 | -$3.54M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.18M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$2.15M |